Financial Network Wealth Advisors LLC Halozyme Therapeutics, Inc. Transaction History
Financial Network Wealth Advisors LLC
- $53.8 Billion
- Q4 2024
A detailed history of Financial Network Wealth Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 29 shares of HALO stock, worth $1,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 28
3.57%
Holding current value
$1,665
Previous $1.6 Million
13.54%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
546Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$763 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$413 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$239 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$198 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...